Total Funding
7
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Inform Genomics develops personalized medicine products for cancer supportive care and inflammatory diseases.
- Stephen Sonis: Chief Scientific Advisor
- Ed Rubenstein: President & CEO
About the Company
Inform Genomics is a private company focused on developing a novel platform of personalized medicine products for cancer supportive care and inflammatory diseases. Their business model leverages existing technology in conjunction with proprietary analytic methods for conducting genome-wide association studies. Product development programs will lead
to commercial, single source laboratory tests consisting of SNP clusters that determine the likelihood of individual patient clinical outcomes to drug therapies. The U.S. market opportunity for these differentiated products exceeds $2 billion annually. Inform Genomics is headquartered in Boston, Massachusetts.
